Evolving antimicrobial chemotherapy for Staphylococcus aureus infections:: Our backs to the wall

被引:19
作者
Daum, RS [1 ]
Seal, JB [1 ]
机构
[1] Univ Chicago, Dept Pediat, Sect Pediat Infect Dis, Chicago, IL 60637 USA
关键词
Staphylococcus aureus staphylococci vancomycin glycopeptide streptogramins lysostaphin;
D O I
10.1097/00003246-200104001-00007
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Staphylococcus aureus is responsible for many nosocomial and community-acquired infections. Its evolving resistance to traditional antimicrobial chemotherapy and emerging prevalence outside of the healthcare environment are serious concerns. This review of the changing epidemiology of methicillin-resistant S, aureus, the emergence of vancomycin (glycopeptide)-resistant isolates, and the mechanisms of resistance to beta -lactams and glycopeptides provides an update for clinicians regarding effective strategies for treatment mechanisms of resistance to beta -lactams and glycopeptides provides an update for clinicians regarding effective strategies for treatment mechanisms of resistance to beta -lactams and glycopeptides provides an update for clinicians regarding effective strategies for treatment.
引用
收藏
页码:N92 / N96
页数:5
相关论文
共 47 条
[1]   Clonal features of community-acquired methicillin-resistant Staphylococcus aureus in children [J].
Abi-Hanna, P ;
Frank, AL ;
Quinn, JP ;
Kelkar, S ;
Schreckenberger, PC ;
Hayden, MK ;
Marcinak, JF .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) :630-631
[2]   Methicillin-resistant Staphylococcus aureus in two child care centers [J].
Adcock, PM ;
Pastor, P ;
Medley, F ;
Patterson, JE ;
Murphy, TV .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02) :577-580
[3]  
[Anonymous], 1999, MMWR-MORBID MORTAL W, V48, P707
[4]  
[Anonymous], MMWR MORB MORTAL WKL
[5]   SYNTHESIS OF PENICILLIN - 6-AMINOPENICILLANIC ACID IN PENICILLIN FERMENTATIONS [J].
BATCHELOR, FR ;
DOYLE, FP ;
NAYLER, JHC ;
ROLINSON, GN .
NATURE, 1959, 183 (4656) :257-258
[6]   COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTION [J].
BERMAN, DS ;
EISNER, W ;
KREISWIRTH, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (25) :1896-1896
[7]   Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates [J].
Boyle-Vavra, S ;
Berke, SK ;
Lee, JC ;
Daum, RS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :272-277
[8]   A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates [J].
Boyle-Vavra, S ;
Labischinski, H ;
Ebert, CC ;
Ehlert, K ;
Daum, RS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :280-287
[9]   LYSOSTAPHIN - ENZYMATIC MODE OF ACTION [J].
BROWDER, HP ;
ZYGMUNT, WA ;
YOUNG, JR ;
TAVORMIN.PA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1965, 19 (03) :383-&
[10]  
CASEWELL MW, 1986, J ANTIMICROB CHEMOTH, V18, P1